His primary areas of study are Immunology, Cytotoxic T cell, Mucosal associated invariant T cell, Major histocompatibility complex and T cell. His Immunology research includes themes of Cancer research and Cell biology. Olivier Lantz has included themes like Antibody and CD8 in his Cytotoxic T cell study.
His studies in Mucosal associated invariant T cell integrate themes in fields like T lymphocyte and Interleukin 17, Cytokine. His Major histocompatibility complex study which covers Microbiology that intersects with Virology, Virus, Minor histocompatibility antigen and Innate immune system. His biological study spans a wide range of topics, including Dendritic cell, MHC class I, Gene rearrangement and Immunity.
Olivier Lantz mainly focuses on Immunology, T cell, Cytotoxic T cell, Mucosal associated invariant T cell and Antigen. As part of his studies on Immunology, he often connects relevant subjects like Cell biology. His T cell research is mostly focused on the topic T-cell receptor.
His Cytotoxic T cell study combines topics in areas such as T lymphocyte and CD8. His CD8 study combines topics from a wide range of disciplines, such as Cancer research and Cellular differentiation. His Mucosal associated invariant T cell research is multidisciplinary, relying on both Minor histocompatibility antigen, Antigen presentation and Microbiology.
Cancer research, T cell, T-cell receptor, Antigen and Immunology are his primary areas of study. His study in Cancer research is interdisciplinary in nature, drawing from both Cell culture, CD8, Lymph node, Cytotoxic T cell and Lung cancer. His T cell research focuses on Cellular differentiation and how it connects with RNA, Umbilical Cord Blood Transplantation and Cord blood.
His T-cell receptor research is multidisciplinary, incorporating elements of Natural killer T cell, Receptor, Molecular biology and Locus. His specific area of interest is Antigen, where Olivier Lantz studies Major histocompatibility complex. His study in Immunology is interdisciplinary in nature, drawing from both Transcriptome and Chronic stress.
His main research concerns Cancer research, T cell, Antigen, Immunology and Immunity. His study looks at the intersection of Cancer research and topics like Cytotoxic T cell with CD8, Monalizumab and Cetuximab. Olivier Lantz is involved in the study of T cell that focuses on Mucosal associated invariant T cell in particular.
Olivier Lantz studies Major histocompatibility complex which is a part of Antigen. In his study, Adjuvant is strongly linked to Cell culture, which falls under the umbrella field of Major histocompatibility complex. His biological study spans a wide range of topics, including Transcriptome, Organ Specificity and Transgene.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
Bernard Escudier;Thierry Dorval;Nathalie Chaput;Fabrice André.
Journal of Translational Medicine (2005)
An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.
Olivier Lantz;Albert Bendelac.
Journal of Experimental Medicine (1994)
CD1 recognition by mouse NK1+ T lymphocytes
Albert Bendelac;Albert Bendelac;Olivier Lantz;Mary E. Quimby;Jonathan W. Yewdell.
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1
Emmanuel Treiner;Livine Duban;Seiamak Bahram;Mirjana Radosavljevic.
Indirect activation of naïve CD4 + T cells by dendritic cell–derived exosomes
Clotilde Théry;Livine Duban;Elodie Segura;Philippe Véron.
Nature Immunology (2002)
Guidelines for the use of flow cytometry and cell sorting in immunological studies
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis.
European Journal of Immunology (2017)
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17–secreting T cells
Mathilde Dusseaux;Mathilde Dusseaux;Emmanuel Martin;Emmanuel Martin;Nacer Serriari;Isabelle Péguillet.
Antimicrobial activity of mucosal-associated invariant T cells
Lionel Le Bourhis;Emmanuel Martin;Emmanuel Martin;Isabelle Péguillet;Isabelle Péguillet;Amélie Guihot.
Nature Immunology (2010)
The Transcription Factor PLZF Directs the Effector Program of the NKT Cell Lineage
Adam K. Savage;Michael G. Constantinides;Jin Han;Damien Picard.
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale André;Caroline Denis;Caroline Soulas;Clarisse Bourbon-Caillet.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: